Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04628494
Title A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Gemcitabine + Oxaliplatin + Rituximab

Epcoritamab

Bendamustine + Rituximab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.